Left ventricular aneurysm as a coronary risk factor independent of overall left ventricular function by Cohen, David E. & Vogel, Robert A.
Left ventricular aneurysm as a coronary risk 
factor independent of overall left ventricular 
function 
Patients with left ventricular aneurysm (LVA) have been shown to have a higher mortality rate 
than those with normal left ventricular function. The purpose of this study was to determine 
whether or not LVA, in patients with coronary artery disease, is a risk factor independent of left 
ventricular function. Thirty-nine patients with angiographically demonstrated segmental 
dyskinesis (LVA group) were retrospectively compared to 28 patients with segmental akinesis 
and ejection fraction less than 60% (control group). There was no significant difference in age, 
ejection fraction, severity of coronary artery disease, cardiac index, or frequency of cardiac 
surgery between the two groups. Compared to control subjects, the LVA group had a 
significantly higher left ventricular end-diastolic pressure and greater tendency to have apical 
involvement. Although electrocardiography, echocardiography, and radioventriculography were 
each highly specific, their sensitivities were only 40% to 60%. Follow-up data were available for 
a mean of 33 months after catheterization. No significant benefit from aneurysmectomy could be 
demonstrated. There was an insignificant trend in the LVA group toward more severe congestive 
heart failure and less angina. There was no significant difference in the reinfarction rate, 
incidence of ventricular tachycardia, or embolism. Mortality rate was 38% in the LVA group and 
32% in the control group (p = 0.59). We conclude that LVA is not an independent risk factor for 
congestive heart failure, angina, ventricular tachycardia, reinfarction, embolism, or death. (AM 
HEART J 111:23, 1986.) 
David E. Cohen, M.D., and Robert A. Vogel, M.D. Ann Arbor, Mich. 
Left ventricular aneurysm (LVA) is a common 
sequela to myocardial infarction, occurring in 10% 
to 30% of patients surviving an acute myocardial 
infarction.‘” Many studies have shown that patients 
with LVA have a higher mortality rate than those 
with normal left ventricular function4v5 and have 
suggested that these patients are particularly sus- 
ceptible to severe ventricular arrhythmias,‘j-lo throm- 
boembolic phenomena,‘, 7, lo and congestive heart 
failure.13 5~7, g-11 
Surgical resection of LVA has been commonly 
performed in an effort to treat these problems, and 
many studies suggest improvement in survival rate 
and functional status after aneurysmectomy or 
aneurysmorrhaphy.sp lo, 12e20 However, these proce- 
dures are associated with a high operative mortality 
rate, and there have been no controlled, randomized, 
prospective studies on the efficacy of these proce- 
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dures. Furthermore, it is not clear whether the 
morbidity and mortality associated with LVA are 
the result of the segmental dysfunction itself or can 
be attributed to the severe overall left ventricular 
dysfunction with which it is often associated. The 
purpose of this study was to determine whether or 
not LVA is an independent risk factor for cardiac 
morbidity and mortality in patients with coronary 
artery disease. 
METHODS 
Patient selection. All cardiac catheterizations (n = 895) 
performed at the University of Michigan Hospital 
between January 1, 1978, and December 31, 1979, were 
reviewed. LVA was defined as any dyskinetic (outward 
systolic motion) segment of the left ventricle. All patients 
with such an abnormality on ventriculography were select- 
ed for study (LVA group). The control group consisted of 
all patients with akinetic segment(s) of the left ventricle 
(no systolic motion), ejection fraction of less than 60%, 
and no areas of dyskinesis. 
Excluded from these patients were those with greater 
than a 15 mm Hg gradient across the aortic valve (two 
patients in the control group and one in the LVA group), 
those with mitral valve areas less than 1.0 cm2 (two 
patients in the control group), and those with greater than 
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Table I. Clinical characteristics of aneurysm and control 
patients at time of catheterization* 
Aneurysm Control 
group group p Value 
No. of patients 

















58 t 9 58 -t 9 
74126 89/11 
92 86 NS 
42 25 NS 
88 86 NS 
10 18 NS 
3 14 NS 
37 21 NS 
37 25 NS 
18 36 <0.05 
68 40 <0.05 
26 53 <0.05 
21 4 -Co.05 
16 4 NS 
NS 
NS 
Abbreviations SD = standard deviation; NS = not significant; MI = myo- 
cardial infarction; CHF = congestive heart failure; VT = ventricular tachy- 
cardia; PM1 = point of maximal impulse; S, = third heart sound, 
Sl = fourth heart sound; JVD = jugular venous distention. 
*Data are expressed as percentage of group with each characteristic unless 
otherwise indicated. 
l+ mitral or aortic insufficiency (one patient in the LVA 
group). Also excluded were those with ventricular septal 
defect (one in the LVA group), those without at least a 
70% stenosis of at least one major coronary artery (one in 
the control group), those who died during cardiac cathe- 
terization (two in the LVA group), those for whom medical 
records were unavailable (two in each group), those in 
whom no coronary angiography was performed (one in the 
control group), and those who bad undergone previous 
cardiac valve replacement (one in each group). There are 
23 patients with akinesis who were excluded because of 
ejection fractions > 60%. Three patients had undergone 
previous coronary artery bypass surgery at the time of 
entry into the study (two in the LVA group and one in the 
control group). After these patients were excluded, the 
LVA group contained 39 patients and the control group, 
28 patients. In the LVA group, four patients had l+ mitral 
insufficiency, one had a 10 mm Hg aortic valve gradient, 
and one had l+ aortic insufficiency. In the control group, 
one patient had a 10 mm Hg aortic valve gradient, one had 
l+ mitral insufficiency, and one had l+ aortic insufficien- 
CY. 
Catheterization data. Catheterization reports on all 
selected patients were reviewed, and the following data 
were obtained: left ventricular end-diastolic pressure, 
cardiac index, coronary angiographic findings, left ventric- 
ular ejection fraction, and quantification of motion of each 
left ventricular segment (anterobasal, anterolateral, api- 
cal, inferior, posterobasal, lateral, and septal) as either 
normal, hypokinetic, akmetic, or dyskinetic. Ventriculo- 
grams were reviewed by an independent observer if the 
Table II. Noninvasive data at time of catheterization* 
Aneurysm Control 




AMI and IMI 13 
No MI 18 
ST segment elevation 41 
Chest X-ray 
Cardiomegaly 33 
LV enlargement 8 
Radionuclide ventriculogram 
Segmental dyskinesis 48 
Two-dimensional echocardiogramr 










Abbreviations: AM1 = anterior myocardial infarction; IMI = inferior myo 
cardial infarction; MI = myocardial infarction: LV = left ventricle; 
NS = not significant. 
*Data are expressed as percentage of group with each characteristic. 
tp Value for observed distribution of AM1 and IMI is 0.07. 
TEchocardiograms were performed in only six aneurysm patients and three 
control patients. 
catheterization report data were ambiguous or inconsis- 
tent. All of the ventriculograms were technically adequate 
and had sufficient opacification for determination of 
regional and global wall motion. Ejection fractions were 
measured on sinus beats only. Postectopic beats were 
excluded for analysis unless these were the only sinus 
beats available. A vessel was considered diseased if a 
stenosis of at least 70% was present. 
Clinical data. The medical record of each patient was 
reviewed. History and physical examination obtained at 
the time of cardiac catheterization were used to determine 
the presence of previous myocardial infarction, the pres- 
ence and severity of angina and congestive heart failure, 
the presence of ventricular arrhythmias and thromboem- 
bolic phenomena, the presence of cardiac risk factors, and 
evidence of abnormal cardiac physical findings. Each 
patient had a standard 12-lead ECG and a chest x-ray 
prior to catheterization. Forty patients underwent multi- 
ple-gated acquisition radionuclide ventriculograms using 
in vivo labeled red blood cells and 16 frames/cardiac cycle 
gating. Several patients had other diagnostic studies 
including exercise tests, ambulatory ECG monitoring, 
radionuclide ventriculography, thallium perfusion studies, 
and invasive electrophysiologic studies, all of which were 
also recorded. 
The follow-up period was defined as commencing with 
the day following cardiac catheterization and ending with 
the most recent available date of follow-up or death. Data 
pertaining to this period were obtained from the medical 
records, by contact with the patients’ physicians, or by 
contact with the patients themselves or their surviving 
family. Information specifically sought included the per- 
formance of cardiac surgery, presence and severity of 
angina pectoris, congestive heart failure and ventricular 
arrhythmias, the presence of thromboembolic phenome- 
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na, and death. If death occurred, information concerning 
the cause of death was obtained. 
Statistical comparisons between the akinetic and dyski- 
netic groups were made by means of Student’s unpaired t 
test for continuous variables and chi square with continu- 
ity correction for discrete variables. 
RESULTS 
Clinical data at the time of catheterization. The 
demographic, historic, and physical examination 
data obtained at the time of catheterization in each 
group are summarized in Table I. There were no 
statistically significant differences between the two 
groups with respect to age, sex, and cardiac morbid- 
ity. The prevalence of cardiac risk factors was 
similar in both groups. Third and fourth heart 
sounds and peripheral edema were more common in 
the LVA group than in the control group. 
Noninvasive data at the time of catheterization. ECG 
and chest x-ray findings are summarized in Table II. 
There was a trend to more old anterior myocardial 
infarctions in the aneurysm group, which 
approached statistical significance. The presence of 
ST segment elevation was very specific for LVA but 
was only present in a minority of patients with this 
lesion. The prevalence of cardiomegaly on chest 
x-ray was significantly higher in the LVA group. 
Radionuclide ventriculography was performed in 
27 patients in the LVA group and in 13 in the 
control group. Dyskinetic segments were seen in 
48% of the LVA patients studied and in 8% of the 
control patients studied. The single patient in the 
control group with dyskinesis shown by radionuclide 
study was alive and free of cardiovascular events 42 
months after catheterization and should not alter 
the conclusions of this study even if the patient 
might be considered misclassified. Four of the six 
patients in the LVA group who underwent two- 
dimensional echocardiography were found to have 
evidence of segmental dyskinesis, whereas only one 
out of three control patients had this echocardio- 
graphic finding. 
Catheterization data. The finding of cardiac cathe- 
terization are outlined in Table III. The two groups 
were well matched for mean ejection fraction (43% 
in the LVA group, 45 % in the control group) and the 
extent and distribution of coronary artery disease. 
There was a significantly higher mean left ventricu- 
lar end-diastolic pressure in the LVA group and a 
lower mean cardiac index which approached statisti- 
cal significance. The distribution of dyskinetic seg- 
ments in the LVA group was markedly different 
from the distribution of akinetic segments in the 
control group, with the apex more frequently 
Table Ill. Cardiac catheterization data* 
Aneurysm Control 
group group p Value 
Mean EF (% 2 SD) 43 + 20 45 zt 15 NS 
Mean LVEDP (mm Hg + SD) 18.1 2 6.7 14.3 A 6.3 <0.05 
Mean CI (L/m/m2 -+ SD) 2.5 f 0.6 2.8 i 0.4 0.07 
Severity of CAD 
Single-vessel disease 20 7 
Double-vessel disease 13 7 
Triple-vessel disease 67 86 
Distribution of CAD 
LAD 95 96 NS 
RCA 77 93 NS 
LCX 64 85 <0.05 
LMCA 5 11 NS 
Wall motion abnormalitiest 
Apex 84 43 <0.05 
Anterolateral 23 28 NS 
Inferior 15 54 <0.05 
Posterobasal 5 43 <0.05 
Lateral 0 11 -co.05 
Septal 5 I4 NS 
Abbreviations: EF = ejection fraction; LVEDP = left ventricular end- 
diastolic pressure; CI = cardiac index; CAD = coronary artery disease; 
LAD = left anterior descending artery; RCA = right coronary artery; 
LCX = left circumflex artery; LMCA = left main coronary artery; 
NS = not significant. 
*Data are expressed as percentage of group with each characteristic unless 
otherwise specified. 
tThese figures represent the distribution of dyskinetic segments in the 
aneurysm group and akinetic segments in the control group. 
involved in the former group and inferior, postero- 
basal, and lateral wall involvement more frequent in 
the latter group. 
Follow-up data. The mean duration of follow-up 
was 33 f 19 months in the LVA group (range 1 to 55 
months) and 31 -t 13 months in the control group 
(range 1 to 47 months) (p = 0.67). Cardiac surgery 
was performed during the follow-up period in 17 
(44%) patients in the LVA group and in 12 (43% ) 
patients in the control group. In all except one 
patient (who had an aneurysmectomy only), all 
procedures consisted of coronary artery bypass 
grafting with an average of 1.8 bypasses/patient in 
the LVA group and 2.5 bypasses/patient in the 
control group. Twelve LVA patients underwent 
concomitant (or isolated in one patient) aneurys- 
mectomy or aneurysmorrhaphy. No valve replace- 
ments were performed, reflecting the exclusion of 
patients with significant valvular disease. The oper- 
ative mortality rate, defined as death within 24 
hours of surgery, was 4 out of 17 LVA patients 
(23%) and 1 out of 12 control patients (8.3%). The 
outcome of medical and surgical therapy in both 
groups is outlined in Fig. 1. 
In an attempt to ascertain the effect of aneurys- 
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Fig. 1. Clinical outcome of surgical and medical manage- 
ment in aneurysm and control groups. n = number of 
patients; Rx = treatment; CABG = coronary artery by- 
pass graft. 
mectomy or aneurysmorrhaphy on symptoms of 
congestive heart failure, Fig. 2 compares the initial 
and follow-up functional status in LVA patients who 
underwent this procedure with those aneurysm 
patients who did not. No clear benefit from this 
procedure could be demonstrated. The overall mor- 
tality rate in the resected group was 58% compared 
to 30% in the unresected group. 
Clinical status at the most recent time of follow- 
up or at the time just prior to death is outlined in 
Table IV. The frequency of clinically evident con- 
gestive heart failure, angina, ventricular tachycar- 
dia, recurrent myocardial infarction, and cerebro- 
vascular events as not significantly different 
between the two groups. In neither group was an 
event identified that was clearly embolic in origin. 
Many of the patients who experienced a cerebrovss- 
cular event had known cerebrovascular disease. 
None of the patients was on chronic anticoagulation 
therapy during the study. 
When angina and congestive heart failure were 
graded by New York Heart Association criteria and 
the two groups compared according to the severity 
of these symptoms, there was no statistically signif- 
icant difference between these two groups (Fig. 3). 
The mortality rate was 38% in the LVA group and 
32% in the control group, a difference which is not 
statistically significant (p = 0.59). Among patients 
in the LVA group, the causes of death were cardiac 
in 11 (one sudden death, four congestive heart 
failure, two ventricular arrhythmia, and four recur- 
rent myocardial infarction), noncardiac in one (can- 
cer), and undetermined in three. Among control 
paitents, the causes of death were cardiac in five 
(one congestive heart failure, two ventricular 
arrhythmia, and two recurrent myocardial infarc- 
tion), noncardiac in three (chronic obstructive pul- 
NO ANEURYSMECTOMY ANEURYSMECTOMY 
nz26 rld2 
MORTALITY ~30% MORTALITY = 58% 
Fig. 2. Severity of congestive heart failure symptoms 
(New York Heart Association classification) in aneurysm 
patients at the time of catheterization (Initial) and at the 
time of latest follow-up. Patients who died during this 
interval are classified according to the most recent status 
while alive. Numbers represent the number of patients 
represented by each line. Left, Patients who did not 
undergo left ventricular aneurysmectomy during this 
interval. Right, Patients who underwent left ventricular 
aneurysmectomy during this interval. 
monary disease, cancer, and cirrhosis), and undeter- 
mined in one patient. 
When death, myocardial infarction, and cerebro- 
vascular accidents were grouped together as end- 
point events, there was still no significant difference 
between the two groups (mean incidences: 20.3% in 
the LVA group and 16.7% in the control group). 
DISCUSSION 
That global left ventricular dysfunction is a major 
prognostic indicator in patients with ischemic heart 
disease has been well established. Whether or not 
segmental left ventricular function has the same 
significance, independent of ejection fraction, has 
not been determined. LVA, the most advanced form 
of segmental dysfunction, is often associated with 
global dysfunction and, therefore, may not be specif- 
ically responsible for the increased morbidity and 
mortality often attributed to it. 
EWier studies. Only two other studies have exam- 
ined the prognostic significance of LVA indepen- 
dent of overall left ventricular function.4s21 Faxon et 
al.,4 by means of data obtained from the Coronary 
Artery Surgery Study, found that the higher $-year 
mortality rate in patients with LVA (defined as 
dyskinesis or akinesis), as compared to patients 
without LVA, was no longer demonstrable when the 
LVA patients were compared to patients without 
LVA but with similar degrees of residual or total left 
ventricular dysfunction. Meizlish et alzl recently 
examined the prognostic significance of LVA 
defined by radionuclide angiography as dyskinesis 
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Table IV. Clinical status at time of latest follow-up* 
Aneurysm Control 
group group p Value 
CHF 32 29 NS 
Angina 50 71 NS 
Recurrent MI 18 7 NS 
Ventricular tachycardia 16 4 NS 
CVA or TIA 5 11 NS 
Death 38 32 NS 
Abbreviations: CHF = congestive heart failure; MI = myocardial infarc- 
tion; CVA = cerebrovascular .sccident; TIA = transient ischemic attack. 
*Data are expressed as percentage of group with each characteristic. 
or akinesis associated with a diastolic contour 
abnormality in the setting of acute anterior trans- 
mural myocardial infarction. They found a 6.7-fold 
greater l-year mortality rate (61% vs 9%) in those 
patients whose infarctions were associated with 
acute LVA formation as compared to those patients 
whose infarctions were not. The Meizlish study 
differs from the Faxon study, as well as the present 
study, because it examines patients with acute (not 
remote) infarction, it uses nuclear (not angiograph- 
ic) techniques, and it uses a different definition of 
LVA. The present study adds to these earlier studies 
by examining the cardiac morbidity as well as the 
mortality rate associated with LVA by assessing the 
effectiveness of surgical resection in a controlled 
(albeit nonrandomized) fashion and by restricting 
the control group to those with discrete segmental 
abnormalities. 
The central issue of this study is of significant 
interest since the traditional therapy of LVA, that 
is, aneurysmectomy, is of unproved efficacy and is 
associated with a high operative mortality rate 
(3.3 % to 50% ).“* 14, 15, ~3, 22-24 Furthermore, the results 
of many studies on the effectiveness of surgical 
resection on cardiac morbidity and mortality are 
highly variable, uncontrolled, and usually compli- 
cated by concomitant revasularization.g* 12mzo 
The definition of LVA in the literature has been 
quite variable, with debate focusing on the degree of 
the necessary wall motion abnormality,4T 5, 16, 21 the 
diastolic contour,4* la* 2L histologic composition,‘* 7 wall 
thickness, and discreteness of its margins.4 Much of 
this disagreement is related to the inherent differ- 
ences between clinical, surgical, and pathologic 
studies. Clearly, the definition of .the term “left 
ventricular aneurysm” is not as important as the 
definition of specific abnormalities of left ventricu- 
lar function which identify a subset of patients with 
distinctive clinical and hemodynamic characteris- 
tics. 
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Fig. 3. Severity of symptoms of aneurysm patients (solid 
bars) and control patients (open bars) at the time of latest 
follow-up. Patients who died during the follow-up period 
are classified according to the most recent status while 
alive. Upper, Severity of angina (New York Heart Associ- 
ation Classification). Lower, Severity of congestive heart 
failure (New York Heart Association classification). None 
of the observed differences between the two groups is 
statistically significant. 
describe a segment of the left ventricle which is 
dyskinetic at rest during ventriculography. The con- 
trol group contained patients with ‘one or more 
segments revealing akinesis (but no dyskinesis) and 
an ejection fraction less than 60%. A population of 
patients with akinesis was chosen as a control group 
for two reasons. A regional wall motion abnormality 
was needed in this group in order to provide a 
population with a reduced mean ejection fraction 
comparable to that of the LVA group while exclud- 
ing those patients with primary (and more likely 
global) myocardial disease ‘who might have a differ- 
ent natural history than those with ischemic (and 
more likely segmental) myocardial disease. Akinesis 
was chosen as the necessary abnormality in the 
control group in order to provide a population of 
28 Cohen and Vogel 
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patients for comparison with as severe a regional 
abnormality as possible short of LVA. If patients in 
the control group with high ejection fractions were 
not excluded, the less severe regional abnormality 
present in this group would have resulted in a higher 
mean ejection fraction than in the LVA group. Since 
ejection fraction is known to have major prognostic 
significance, failure to have comparable mean ejec- 
tion fractions in the two groups would have made 
conclusions about the prognostic significance of 
LVA impossible. Whether the lower mean ejection 
fraction in the LVA group (prior to the previously 
mentioned exclusions) can be attributed solely to 
the systolic expansion of the aneurysm or is, in part, 
the result of a greater degree of overall left ventric- 
ular dysfunction cannot be ascertained from this 
study. 
Morbidity of left ventricular aneurysm. The major 
clinical problems most frequently attributed to LVA 
are congestive heart failure, malignant ventricular 
arrhythmias, thromboembolic phenomena, and an 
increased mortality rate. This study provides evi- 
dence that patients with LVA are at no more risk for 
these problems than are patients with similar ejec- 
tion fractions and coronary artery disease but who 
are free of LVA. 
The reported incidence of congestive heart failure 
in patients with LVA ranges from 21% to 86 % .I, 7, g-1* 
In this study, 32% of patients with LVA had 
congestive heart failure, which was not statistically 
different from the incidence of 29% in the control 
group. This finding suggests that the experimentalz4 
and theoretic25 hemodynamic burden imposed by an 
expansile segment of the left ventricle may be 
clinically important only insofar as it reduces the 
overall ejection fraction. 
Thromboembolic phenomena have frequently 
been reported to be associated with LVA, the inci- 
dences ranging from 0 % to 20% in clinical 
studies5s lo, I1 and 9% to 52% in pathologic studies.ls’ 
The frequent discrepancy between clinical and 
pathologic studies may reflect either the high inci- 
dence of clinically occult emboli, the failure to 
recognize a vascular event as embolic in nature, or 
the inherent differences in patient populations. 
None of the patients in this study was anticoagu- 
lated, and none had a clearly embolic event. There 
are several cerebrovascular events in both groups, 
but all of these were clinically or angiographically 
believed to be the result of intrinsic cerebrovascular 
disease. 
With the widespread emergence of endocardial 
mapping and other invasive electrophysiologic 
studies,17*26 new antiarrhythmic agents, and surgical 
treatment of ventricular arrhythmias,gs 12* 13, 26 there is 
much interest in the identification of patients at 
high risk for malignant arrhythmias.8r l7 Malignant 
arrhythmias have been reported to occur in 14% to 
40% of patients with LVA.7-‘o Whether this inci- 
dence is a reflection of a peculiar property of LVA or 
simply a manifestation of the severe underlying 
heart disease has not yet been addressed. The 
results of this study support the latter view in that 
the incidence of ventricular tachycardia and fibrilla- 
tion was not significantly different between the two 
groups. It must be acknowledged, however, that 
ambulatory monitoring was not routinely performed 
and that there was a trend (which fails to reach 
statistical significance) toward more ventricular 
tachycardia in the LVA group. This observation is in 
agreement with another recent study addressing this 
issue.8 
Death from LVA. The mortality rates were high in 
each group but not significantly different from each 
other. In comparison with the study by Faxon et a1.,4 
in which the mean ejection fraction among patients 
with LVA was similar to that of this study, the 
present mortality rate was somewhat higher (38% 
over 33 months compared to 21% over 36 months). 
This may reflect differences in the timing of the 
index catheterization, the slightly higher mean age 
and higher incience of congestive heart failure in 
this study, or a reflection of the difference in 
definition of LVA. Nevertheless, this study agrees 
with the conclusion of the Faxon study that LVA 
does not increase the mortality rate independent of 
overall left ventricular function. These conclusions 
are in sharp contrast to those of the study by 
Meizlish et a1.2’ It may be that LVA is associated 
with an increased mortality rate during the first year 
of its formation but not thereafter. Alternatively, 
the differences may reflect the use of nuclear tech- 
niques to make the diagnosis of LVA which, in the 
present study, is very specific but not very sensitive 
when compared to angiographic techniques. The 
mortality figures from other studies of LVA are 
highly variable and uncontrolled, with most of the 
earlier studies showing much higher mortality rates, 
such as 73 % in 3 years,‘, 28 73 % at 5 years,’ or an 
average postmyocardial infarction survival rate of 
only 4.8 yearsZg 
Another interesting finding was that the 12 patients 
who underwent either aneurysmectomy or aneu- 
rysmorrhaphy did not demonstrate any significant 
functional advantage over those 26 patients in whom 
these procedures were not performed and, in fact, had 
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a much higher mortality rate. Although these num- 
bers are small, the data retrospective, and the patients 
nonrandomized, this is the first published series of 
surgical therapy in which a control group of unre- 
sected patients is available for comparison. 
Clinical characteristics of LVA. It is interesting that 
clinical different&ion between the two groups was 
not reliably possible, even with the use of noninva- 
sive diagnostic studies. Two-dimensional echocar- 
diography, electrocardiography, and radionuclide 
ventriculography were reasonably specific (67 % , 
85 % , and 92 % , respectively) but had surprisingly 
low sensitivities (67 % ,41% , and 48%) respectively). 
This contrasts with the results of other studies on 
the utility of these techniques in the diagnosis of 
LVA 30.33 
The higher mean left ventricular end-diastolic 
pressure in the WA group was statistically signifi- 
cant and seems to indicate decreased diastolic com- 
pliance of the aneurysmal left ventricle, since the 
mean ejection fraction and mean cardiac index were 
not significantly different between the two groups. 
This property is in obvious contrast to the higher 
systolic compliance of a dyskinetic segment when 
compared to an akinetic one. This finding is in 
agreement with an earlier study by Klein et alz6 
There was an interesting, although not statistical- 
ly significant, trend toward less severe coronary 
artery disease, less angina, and fewer bypassed 
vessels in the patients with LVA. Another interest- 
ing observation is that, despite the similar distribu- 
tion of coronary artery disease (including the left 
anterior descending artery) in the two groups, there 
was a striking predilection for aneurysms to involve 
the apical segment of the left ventricle. Eighty-five 
percent of the aneurysms involved this segment 
compared to only 43% of the akinetic segments in 
the control group. This predilection is in agreement 
with many other studies.‘~4~g**6, *’ Whether or not 
these observed differences in hemodynamics, coro- 
nary disease, and distribution of segmental dysfunc- 
tion between these two groups are identifying dis- 
tinct subsets of patients remains to be determined. 
In summary, this study suggests that LVA, in 
patients with coronary artery disease, is not a signif- 
icant risk factor for cardiac morbidity or mortality 
when compared with patients without aneurysms 
but with similar degrees of left ventricular dysfunc- 
tion as measured by ejection fraction. 
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Increased left ventricular volume following 
myocardial infarction in man 
To determine the relationship between left ventricular volumes and the magnitude of wall motion 
abnormality in the chrontc post myocardial infarction period, the right anterior oblique left 
ventrlculogram was analyzed in 55 patients with left anterior descending coronary artery 
disease. The size of the infarct segment was determined by measuring the percentage of the 
circumference of the left ventricular silhouette that was akinetic and/or dyskinetic. Four groups 
of patients were defined with increasing degrees of wall motion abnormality based on the 
percent of the diastolic perimeter that was akinetic and/or dyskinetic. Marked increases in 
end-dtastolic and end-systolic volumes were observed across groups of increasing wall motion 
abnormality. These large increases in volume could not be accounted for by an increase in filling 
pressures. Ejection fraction fell in proportion to the increase in wail motion abnormality across 
groups. Thts study demonstrated that in the chronic phase of infarction, left ventricular 
remodeling results in alterations in left ventricular volumes that are proportional to the degree of 
wall motton abnormality. (AM HEART J 111:30, 1986.) 
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